Nokia CEO admits to delays in rolling out 5G
May 21, 2019Global stocks rally as U.S. eases Huawei restrictions
May 21, 2019Merck buys Peloton to expand its kidney cancer treatment portfolio
at
U.S. drugmaker Merck & Co Inc on Tuesday agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, gaining access to the privately held company’s lead kidney cancer drug candidate.
Powered by WPeMatico
